Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose
Dr Reddy’s Laboratories (DRL) has launched docetaxel injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of taxotere (docetaxel injection) in the US market. DRL’s ANDA is approved by the United States Food & Drug Administration (US FDA).
The taxotere brand and generic has US sales of approximately $218 million MAT for the most recent twelve months ending in September 2014 according to IMS Health.
DRL’s docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution with a diluent and is ready to add to the intravenous infusion solution.
EP News Bureau- Mumbai
- Advertisement -